<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on November 19, 2021</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT03917771</url>
  </required_header>
  <id_info>
    <org_study_id>IJM-EDL- 2017-01</org_study_id>
    <nct_id>NCT03917771</nct_id>
  </id_info>
  <brief_title>Early Detection of Lower Extremity Lymphedema After Lymphadenectomy in Gynecological Cancer</brief_title>
  <official_title>Study to Evaluate the Efficacy of Early Detection of Lower Extremity Lymphedema After Lymphadenectomy in Gynecological Cancer and Implantation of the Protocol</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Hospital Donostia</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Hospital Donostia</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
    <is_fda_regulated_drug>No</is_fda_regulated_drug>
    <is_fda_regulated_device>No</is_fda_regulated_device>
  </oversight_info>
  <brief_summary>
    <textblock>
      This study aims to detect and treat early lower limb lymphedema secondary to lymphadenectomy&#xD;
      with the aim of increasing the quality of life of patients with this chronic condition.&#xD;
&#xD;
      To this end, a group of patients (treatment group) will be referred to the Rehabilitation&#xD;
      service for a previous consultation and after surgery where lymphedema could be detected&#xD;
      early. In addition, the usual follow-up will be carried out in Gynecology Oncology&#xD;
      consultation (GO). In the second group, also called control, will be performed the usual&#xD;
      follow-up in GO.&#xD;
&#xD;
      For this we randomize to one of these two groups. The research project has the favorable&#xD;
      report of the Center's Clinical Research Ethics Committee&#xD;
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      METHODOLOGY:&#xD;
&#xD;
        1. Type of study: A) Randomized clinical trial B) Prospective cohort observational study&#xD;
&#xD;
        2. Study period: from January 2017 to December 2017.&#xD;
&#xD;
        3. Scope: health area of the province of Gipuzkoa and the University Hospital of Donostia&#xD;
           as a reference center.&#xD;
&#xD;
        4. Selection of the population:&#xD;
&#xD;
           4.1. The inclusion criteria will be: A) Diagnostic gynecological cancer patients&#xD;
           submitted to bilateral laparoscopic pelvic lymphadenectomy as laparotomics (B: Sentinel&#xD;
           Node Biopsy study, SNB) within the usual surgical protocol, with expected survival&#xD;
           greater than 12 weeks and adequate liver, renal and medullary functions to accept And&#xD;
           sign informed consent 4.2. The exclusion criteria for the study will be: Blood clotting&#xD;
           or hematological disorders, previous thromboembolic disease and history of lymphatic&#xD;
           system disease (lymphedema or lymphocele), contraindication for physiotherapy or who do&#xD;
           not wish to participate and / or do not sign informed consent.&#xD;
&#xD;
           4.3. Sample size: A) Assuming that according to previous studies the overall incidence&#xD;
           of lymphedema after LPL is 21% (Hareyama et al), its estimated that a minimum sample of&#xD;
           44 patients will bi needed in order to be able to demonstrate at least 4-fold detection&#xD;
           (Torres et al) of Lymphedemas with early follow-up with alpha = 0.05 and beta = 0.2,&#xD;
           estimating that habitual follow-up detects 13% of lymphedema ( Mohler III et al).&#xD;
&#xD;
           4.4. Recruitment Process: Will be selected consecutively and offered to participate in&#xD;
           the study.&#xD;
&#xD;
        5. 5.1 Intervention: A) After diagnosis and programming for surgery at the GO consultation,&#xD;
           circometry is performed by a trained nurse. During the admission, the nurse delivers and&#xD;
           explains recommendations sheet and is offered to participate in the clinical trial&#xD;
           giving him the Informed Consent (IC) and Information Sheet created for this purpose. In&#xD;
           case of accepting and signing the IC, it is randomized (total randomization) according&#xD;
           to system of envelopes with code.&#xD;
&#xD;
      Distribution of the intervention;&#xD;
&#xD;
        -  Treatment group: Face-to-face consultation in Rehabilitation for early detection of&#xD;
           lymphedema after surgery (1,6,12 months). Lower Limb measurement and care education&#xD;
&#xD;
        -  Control group: The usual follow-up will be carried out in GO consultation (0,1,6,12&#xD;
           months)&#xD;
&#xD;
      The pelvic lymphadenectomy will be performed by the same surgical team using a&#xD;
      transperitoneal approach. The limits of lymph node dissection will be: the psoas muscle,&#xD;
      laterally, the postero-medially internal iliac artery, the bifurcation of the common iliac&#xD;
      artery cranially, where it crosses the ureter, and caudally the origin of the epigastric&#xD;
      vessels, to level of the deep circumflex iliac vein.&#xD;
&#xD;
      B) After diagnosis and programming for surgery at the GO consultation, circometry is&#xD;
      performed by trained and yearly nurse. During the entrance, it is delivered and explains the&#xD;
      recommendations sheet. SNB is performed by detecting sentinel ganglion from the above&#xD;
      mentioned areas according to the protocol of the service. The usual follow-up will be carried&#xD;
      out in GO consultation (0,1,6,12 months)&#xD;
    </textblock>
  </detailed_description>
  <overall_status>Completed</overall_status>
  <start_date type="Actual">April 1, 2017</start_date>
  <completion_date type="Actual">August 1, 2018</completion_date>
  <primary_completion_date type="Actual">August 1, 2018</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Parallel Assignment</intervention_model>
    <intervention_model_description>Recruitment Process: patients will be selected consecutively and offered to participate in the study</intervention_model_description>
    <primary_purpose>Diagnostic</primary_purpose>
    <masking>Single (Outcomes Assessor)</masking>
    <masking_description>randomization according to system of envelopes with code</masking_description>
  </study_design_info>
  <primary_outcome>
    <measure>Efficacy of the implantation of a standardized postoperative follow-up for the early detection of lymphedema secondary to lymphadenectomy in gynecological cancer</measure>
    <time_frame>12 months</time_frame>
    <description>Lower Limb measurement secondary to lymphadenectomy in gynecological cancer</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>Implementation of educational strategy for patients and professionals</measure>
    <time_frame>12 months</time_frame>
    <description>Care education questionnaire results</description>
  </secondary_outcome>
  <number_of_arms>2</number_of_arms>
  <enrollment type="Actual">44</enrollment>
  <condition>Lymphedema of Limb</condition>
  <condition>Sentinel Lymph Node</condition>
  <arm_group>
    <arm_group_label>Early lymphedema detection</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>Face-to-face consultation in Rehabilitation for early detection of lymphedema after surgery. Lower Limb measurement and care education</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Usual follow-up</arm_group_label>
    <arm_group_type>Active Comparator</arm_group_type>
    <description>The usual follow-up will be carried out in GO consultation (0,1,6,12 months)</description>
  </arm_group>
  <intervention>
    <intervention_type>Other</intervention_type>
    <intervention_name>Early lymphedema detection</intervention_name>
    <description>Face-to-face consultation in Rehabilitation for early detection of lymphedema after surgery (1,6,12 months). Lower Limb measurement and care education</description>
    <arm_group_label>Early lymphedema detection</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Other</intervention_type>
    <intervention_name>Usual follow-up</intervention_name>
    <description>Usual follow-up carried out in GO consultation</description>
    <arm_group_label>Usual follow-up</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:&#xD;
&#xD;
          -  A) Diagnostic gynecological cancer patients submitted to bilateral laparoscopic pelvic&#xD;
             lymphadenectomy as laparotomics (B: Sentinel Node Biopsy study, SNB) within the usual&#xD;
             surgical protocol, with expected survival greater than 12 weeks and adequate liver,&#xD;
             renal and medullary functions to accept And sign informed consent&#xD;
&#xD;
        Exclusion Criteria:&#xD;
&#xD;
          -  The exclusion criteria for the study will be: Blood clotting or hematological&#xD;
             disorders, previous thromboembolic disease and history of lymphatic system disease&#xD;
             (lymphedema or lymphocele), contraindication for physiotherapy or who do not wish to&#xD;
             participate and / or do not sign informed consent.&#xD;
      </textblock>
    </criteria>
    <gender>Female</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>85 Years</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>IBON JAUNARENA</last_name>
    <role>Principal Investigator</role>
    <affiliation>Hospital Donostia</affiliation>
  </overall_official>
  <location>
    <facility>
      <name>Donostia Hospital</name>
      <address>
        <city>San Sebasti√°n</city>
        <state>Gipuzkoa</state>
        <zip>20014</zip>
        <country>Spain</country>
      </address>
    </facility>
  </location>
  <location_countries>
    <country>Spain</country>
  </location_countries>
  <verification_date>April 2019</verification_date>
  <study_first_submitted>August 16, 2018</study_first_submitted>
  <study_first_submitted_qc>April 13, 2019</study_first_submitted_qc>
  <study_first_posted type="Actual">April 17, 2019</study_first_posted>
  <last_update_submitted>April 13, 2019</last_update_submitted>
  <last_update_submitted_qc>April 13, 2019</last_update_submitted_qc>
  <last_update_posted type="Actual">April 17, 2019</last_update_posted>
  <responsible_party>
    <responsible_party_type>Principal Investigator</responsible_party_type>
    <investigator_affiliation>Hospital Donostia</investigator_affiliation>
    <investigator_full_name>IBON JAUNARENA</investigator_full_name>
    <investigator_title>Oncology Gynecologist</investigator_title>
  </responsible_party>
  <keyword>physiotherapy</keyword>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Lymphedema</mesh_term>
  </condition_browse>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

